PL2918286T3 - Preparat farmaceutyczny zawierający insulinę w postaci krystalicznej, jak również w formie rozpuszczonej - Google Patents
Preparat farmaceutyczny zawierający insulinę w postaci krystalicznej, jak również w formie rozpuszczonejInfo
- Publication number
- PL2918286T3 PL2918286T3 PL15161696T PL15161696T PL2918286T3 PL 2918286 T3 PL2918286 T3 PL 2918286T3 PL 15161696 T PL15161696 T PL 15161696T PL 15161696 T PL15161696 T PL 15161696T PL 2918286 T3 PL2918286 T3 PL 2918286T3
- Authority
- PL
- Poland
- Prior art keywords
- crystalline
- well
- pharmaceutical preparation
- preparation containing
- containing insulin
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200401519 | 2004-10-05 | ||
| EP15161696.8A EP2918286B1 (en) | 2004-10-05 | 2005-10-05 | Pharmaceutical preparation containing insulin in crystalline as well as in solubilized form |
| PCT/EP2005/055017 WO2006037789A1 (en) | 2004-10-05 | 2005-10-05 | A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
| EP20050792052 EP1802329B1 (en) | 2004-10-05 | 2005-10-05 | A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2918286T3 true PL2918286T3 (pl) | 2020-06-29 |
Family
ID=35428106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05792052T PL1802329T3 (pl) | 2004-10-05 | 2005-10-05 | Formulacja farmaceutyczna zawierająca krystaliczną insulinę oraz rozpuszczoną insulinę |
| PL15161696T PL2918286T3 (pl) | 2004-10-05 | 2005-10-05 | Preparat farmaceutyczny zawierający insulinę w postaci krystalicznej, jak również w formie rozpuszczonej |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05792052T PL1802329T3 (pl) | 2004-10-05 | 2005-10-05 | Formulacja farmaceutyczna zawierająca krystaliczną insulinę oraz rozpuszczoną insulinę |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7884181B2 (pl) |
| EP (4) | EP1802329B1 (pl) |
| JP (1) | JP5080259B2 (pl) |
| KR (1) | KR101238184B1 (pl) |
| CN (2) | CN102772788B (pl) |
| AU (1) | AU2005291233B2 (pl) |
| BR (1) | BRPI0516464B8 (pl) |
| CA (1) | CA2581798A1 (pl) |
| CY (1) | CY1124650T1 (pl) |
| DK (1) | DK2918286T3 (pl) |
| ES (3) | ES2774354T3 (pl) |
| HU (1) | HUE048806T2 (pl) |
| LT (1) | LT2918286T (pl) |
| MX (1) | MX2007003897A (pl) |
| PL (2) | PL1802329T3 (pl) |
| PT (1) | PT2918286T (pl) |
| RU (1) | RU2389503C2 (pl) |
| SI (1) | SI2918286T1 (pl) |
| WO (1) | WO2006037789A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065138A1 (en) * | 2006-11-29 | 2008-06-05 | Novo Nordisk A/S | Novel insulin crystal and method for preparing the crystal |
| CN102219851B (zh) * | 2011-05-09 | 2012-05-30 | 甘李药业有限公司 | 甘精胰岛素结晶的制备方法 |
| MX2015006997A (es) * | 2012-12-26 | 2015-09-23 | Wockhardt Ltd | Composicion farmaceutica. |
| JP6641280B2 (ja) | 2014-01-09 | 2020-02-05 | サノフイＳａｎｏｆｉ | インスリンアナログおよび／またはインスリン誘導体の安定化された医薬製剤 |
| RU2014120626A (ru) * | 2014-05-22 | 2015-11-27 | Владимир Андреевич Сабецкий | Инсулинсодержащий препарат пролонгированного действия |
| CN105535942B (zh) * | 2016-01-28 | 2017-07-28 | 通化东宝药业股份有限公司 | 一种赖脯胰岛素硫酸鱼精蛋白制剂的制备方法及其制备的赖脯胰岛素硫酸鱼精蛋白制剂 |
| WO2017163159A1 (en) * | 2016-03-21 | 2017-09-28 | Wockhardt Limited | Biphasic pharmaceutical composition of insulin human |
| WO2022268208A1 (zh) * | 2021-06-25 | 2022-12-29 | 甘李药业股份有限公司 | 含酰化胰岛素的药物组合物 |
| CN113248591B (zh) * | 2021-07-08 | 2021-09-28 | 北京惠之衡生物科技有限公司 | 一种门冬胰岛素结晶工艺 |
| CN113384529B (zh) * | 2021-07-08 | 2021-11-26 | 北京惠之衡生物科技有限公司 | 一种门冬胰岛素注射液及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB889769A (en) * | 1957-07-18 | 1962-02-21 | Nordisk Insulinlab | Slowly acting insulin preparation in crystalline form |
| DK72793D0 (da) | 1993-06-21 | 1993-06-21 | Novo Nordisk As | Nyt produkt |
| US5461031A (en) * | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
| US5474978A (en) | 1994-06-16 | 1995-12-12 | Eli Lilly And Company | Insulin analog formulations |
| CA2258099A1 (en) * | 1996-06-20 | 1997-12-24 | Novo Nordisk A/S | Insulin preparations containing carbohydrates |
| US5866538A (en) | 1996-06-20 | 1999-02-02 | Novo Nordisk A/S | Insulin preparations containing NaCl |
| HU228094B1 (en) | 1996-06-20 | 2012-10-29 | Novo Nordisk As | Insulin preparations containing nacl |
| US5948751A (en) | 1996-06-20 | 1999-09-07 | Novo Nordisk A/S | X14-mannitol |
| AU2002346490A1 (en) * | 2001-12-20 | 2003-07-09 | Eli Lilly And Company | Insulin molecule having protracted time action |
| EP1605967A1 (en) * | 2003-03-13 | 2005-12-21 | Novo Nordisk A/S | Novel nph insulin preparations |
-
2005
- 2005-10-05 SI SI200532272T patent/SI2918286T1/sl unknown
- 2005-10-05 CA CA002581798A patent/CA2581798A1/en not_active Withdrawn
- 2005-10-05 HU HUE15161696A patent/HUE048806T2/hu unknown
- 2005-10-05 ES ES15160523T patent/ES2774354T3/es not_active Expired - Lifetime
- 2005-10-05 ES ES05792052.2T patent/ES2544329T3/es not_active Expired - Lifetime
- 2005-10-05 RU RU2007111879/15A patent/RU2389503C2/ru active
- 2005-10-05 JP JP2007535163A patent/JP5080259B2/ja not_active Expired - Fee Related
- 2005-10-05 BR BRPI0516464A patent/BRPI0516464B8/pt not_active IP Right Cessation
- 2005-10-05 LT LTEP15161696.8T patent/LT2918286T/lt unknown
- 2005-10-05 PT PT151616968T patent/PT2918286T/pt unknown
- 2005-10-05 KR KR1020077007794A patent/KR101238184B1/ko not_active Expired - Fee Related
- 2005-10-05 DK DK15161696.8T patent/DK2918286T3/da active
- 2005-10-05 ES ES15161696T patent/ES2779957T3/es not_active Expired - Lifetime
- 2005-10-05 WO PCT/EP2005/055017 patent/WO2006037789A1/en not_active Ceased
- 2005-10-05 PL PL05792052T patent/PL1802329T3/pl unknown
- 2005-10-05 US US11/664,407 patent/US7884181B2/en active Active - Reinstated
- 2005-10-05 EP EP20050792052 patent/EP1802329B1/en not_active Expired - Lifetime
- 2005-10-05 CN CN201210248925.9A patent/CN102772788B/zh not_active Expired - Fee Related
- 2005-10-05 EP EP15160523.5A patent/EP2926828B1/en not_active Expired - Lifetime
- 2005-10-05 CN CN2005800339452A patent/CN101035557B/zh not_active Expired - Fee Related
- 2005-10-05 EP EP15161696.8A patent/EP2918286B1/en not_active Expired - Lifetime
- 2005-10-05 EP EP20158951.2A patent/EP3689366A1/en not_active Withdrawn
- 2005-10-05 PL PL15161696T patent/PL2918286T3/pl unknown
- 2005-10-05 MX MX2007003897A patent/MX2007003897A/es active IP Right Grant
- 2005-10-05 AU AU2005291233A patent/AU2005291233B2/en not_active Ceased
-
2020
- 2020-03-23 CY CY20201100270T patent/CY1124650T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200506941B (en) | Improvements in or relating to drive mechanisms suitable for use in drug delivery devices | |
| IL247788A0 (en) | Conjugated medicinal composition | |
| GB0310300D0 (en) | Nanocomposite drug delivery composition | |
| ZA200700632B (en) | Non-skin penetrating reconstituting syringe | |
| IL177480A0 (en) | Pharmaceutical composition | |
| GB0327723D0 (en) | Pharmaceutical compositions | |
| GB0300427D0 (en) | Pharmaceutical composition | |
| IL173527A0 (en) | Pharmaceutical composition containing water soluble drug | |
| IL183929A0 (en) | Use of inerferon - ?? in the preparation of a medicament | |
| IL179933A0 (en) | Pharmaceutical compositions containing proteosome based compositions | |
| EP1757273A4 (en) | PREPARATION FOR ORAL ADMINISTRATION | |
| EP1731183A4 (en) | SOLID PHARMACEUTICAL PREPARATION FOR DIALYSIS | |
| EP1699458A4 (en) | PHARMACEUTICAL COMPOSITION | |
| SI1592457T1 (sl) | Konjugat folat-vinblastin kot zdravilo | |
| HUE048806T2 (hu) | Inzulin kristályos, valamint szolubilizált formáját tartalmazó gyógyászati készítmény | |
| IL166114A0 (en) | Long-acting controlled-release pharmaceutical preparation for use in the oral cavity | |
| HU0401177D0 (en) | Pharmaceutical composition | |
| GB2411355B (en) | Pharmaceutical composition | |
| EP1600445A4 (en) | CURATIVE PREPARATION | |
| GB0300885D0 (en) | Pharmaceutical composition | |
| GB0425255D0 (en) | Pharmaceutical composition | |
| ZA200701932B (en) | Pharmaceutical composition | |
| ZA200700844B (en) | Quinolone-containing medicinal composition | |
| IL177456A0 (en) | Substituted azetidine compounds, their preparation and use as medicaments | |
| EP1792620A4 (en) | MEDICAL COMPOSITION WITH AN AGENT AGAINST DIABETES |